Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma-Reference-Cited by-同舟云学术

Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma

Published:2017-01-06 Issue:2 Volume:9 Page:1280-1292
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Deng Caifeng¹,Zhang Quan²,Fu Yao¹,Sun Xun¹^ORCID,Gong Tao¹^ORCID,Zhang Zhirong¹^ORCID

Affiliation:

1. Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, China

2. School of Pharmacy, Chengdu Medical College, Chengdu 610083, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.6b13738

Reference70 articles.

1. Emerging trends in the epidemiology of melanoma